Metagenomi, Inc. - MGX Tezkor likvidlik koeffitsiyenti

Metagenomi Inc. - MGX emitenti grafik logotipi

GURU.Markets platformasidagi Metagenomi, Inc. (MGX) kotirovkalarining ushbu grafigi, yirik gen modifikatsiyasi litsenziyalash hamkorlarining to'lovlari bilan qo'llab-quvvatlanadigan 4.47 darajasini ko'rsatmoqda. Biznes yuqori aniqlikdagi CRISPR tahrirlash sohasidagi nufuzli ishlanmalarga tayanadi va sanoat yetakchilari bilan hamkorlikda irsiy patologiyalarni tuzatish uchun zamonaviy vositalarni yaratish orqali texnologik xavflarni minimallashtiradi.

Metagenomi Inc. (MGX) - Kritik likvidlik 21.02.2024dan 30.10.2026gacha

metagenomi.co (MGX) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Aksiya kotirovkalari Metagenomi, Inc|MGX - Tahlilchilarning prognoz narxlari
- emitentning bozor qiymati haqida ma'lumotlar:
Bozor kapitallashuvi Metagenomi, Inc|MGX - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Metagenomi|MGX - Biznesning balans qiymati|Bozor kapitallashuvining balans qiymatiga nisbati metagenomi.co|MGX - Kompaniya aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Metagenomi, Inc.|MGX - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Qisqa muddatli qarzning o'z kapitaliga nisbati Metagenomi|MGX - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Metagenomi, Inc|MGX - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Metagenomi|Tezkor likvidlik ko‘rsatkichi metagenomi.co
- foyda va baholash multiplikatorlari ko'rsatkichlari:
MGX - Yakuniy foyda
Kompaniyaning har tomonlama tahlili:Metagenomi, Inc.
Metagenomi ishlab chiqargan mahsulot

Tezkor koeffitsient kompaniyaning illikvid zaxiralarni butunlay istisno qilgan holda, naqd pul va debitorlik qarzlari yordamida qisqa muddatli majburiyatlarni zudlik bilan to'lash qobiliyatini o'lchaydi. Ushbu grafikdagi tezkor likvidlik tahlili Metagenomi, Inc. (MGX) moliyaviy barqarorligini baholash imkonini beradi, uning universal genom tahrirlash platformasini kengaytirish strategiyasi global dori ishlab chiqarishni ta'minlash uchun sezilarli miqdordagi likvid naqd pul zaxirasini talab qiladi.

Asosiy raqobatchilar

TEM (Tempus) - Tezkor likvidlik ko‘rsatkichi|QGEN: Oraliq likvidlik koeffitsiyenti|IONS (Ionis Pharmaceuticals) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti repligen.com|Tezkor likvidlik koeffitsiyenti RNA|CRISPR Therapeutics Inc (CRSP) - Kritik likvidlik|Tezkor likvidlik koeffitsiyenti WGS (Sema4)|Ultragenyx Corp (RARE) - Shoshilinch likvidlik|BEAM - Tezkor likvidlik|SRPT (sarepta.com) - Shoshilinch likvidlik koeffitsiyenti|Twist Bioscience, Inc. (TWST) - Tezkor likvidlik|Shoshilinch likvidlik 10x Genomics Inc (TXG)|Tezkor likvidlik Intellia|Tezkor likvidlik ko‘rsatkichi Stoke Corp (STOK)|Tezkor likvidlik koeffitsiyenti BLFS|Oraliq qoplama koeffitsiyenti wavelifesciences.com|Maze Therapeutics - Tezkor likvidlik ko‘rsatkichi|Oraliq qoplash koeffitsiyenti SION|Prime Medicine Corp - Tezkor likvidlik koeffitsiyenti|Oraliq qoplama koeffitsiyenti Taysha Corp TSHA|uniQure N.V. (QURE) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti MGTX|RGNX (REGENXBIO) - Tezkor likvidlik koeffitsiyenti|Tezkor likvidlik ko‘rsatkichi Solid Biosciences Inc (SLDB)|Tezkor likvidlik ko‘rsatkichi OCGN (Ocugen Corp)|Oraliq qoplama koeffitsiyenti PacBio Corp|Tezkor likvidlik Benitec Biopharma Inc. BNTC|DSGN - Tezkor likvidlik ko‘rsatkichi|Rocket Pharmaceuticals, Inc. - Tezkor likvidlik koeffitsiyenti|Kritik likvidlik 4DMT (FDMT)|LXEO (lexeotx.com) - Tezkor likvidlik ko‘rsatkichi|Shoshilinch likvidlik koeffitsiyenti KRRO|EDIT (Editas Medicine, Inc.) - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik koeffitsiyenti SLN (silence-therapeutics.com)|Tezkor likvidlik ProQR Therapeutics N.V. (PRQR)|codexis.com - Shoshilinch likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti SGMO (Sangamo)|Tezkor likvidlik koeffitsiyenti Nautilus Biotechnology, Inc. NAUT|DTIL - Tezkor likvidlik|Generation Bio Co. (GBIO) - Tezkor likvidlik ko‘rsatkichi|BOLD: Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik Exicure (XCUR)|Tezkor likvidlik ko‘rsatkichi IMNN|PHIO (RXi Pharmaceuticals) - Oraliq likvidlik koeffitsiyenti|Tezkor likvidlik koeffitsiyenti MBIO|Tezkor likvidlik koeffitsiyenti transcodetherapeutics.com (RNAZ)|Tezkor likvidlik koeffitsiyenti BNGO (Bionano Genomics)|Kritik likvidlik Applied DNA Sciences Inc|Bluebird Bio - Tezkor likvidlik koeffitsiyenti|Shoshilinch likvidlik ImmunoPrecise Antibodies|Omega Therapeutics (OMGA) - Tezkor likvidlik|Shoshilinch likvidlik koeffitsiyenti OMIC|Tezkor likvidlik Regulus Therapeutics Inc.|Shoshilinch likvidlik Syros Pharmaceuticals Inc. SYRS|Tezkor likvidlik Codex DNA (TBIO)|Tezkor likvidlik ko‘rsatkichi TRACON Pharmaceuticals, Inc TCON|Tezkor likvidlik koeffitsiyenti UBX (Unity Biotechnology)